Cross-sectional Study of Prevalence Rate of Abdominal Aortic Aneurysm in OSAHS Patients From BTCH
NCT ID: NCT03431038
Last Updated: 2018-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1800 participants
OBSERVATIONAL
2017-09-01
2020-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening for Abdominal Aortic Aneurysms in the General Practice by Ultraportable Ultrasound
NCT05617326
Screening for Abdominal Aortic Aneurysm and Abdominal Aortic Atherosclerosis by Hand-Held Ultrasonography
NCT01679288
Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer
NCT06775821
The Inter and Intra Reliability of Cardiopulmonary Exercise Testing in Abdominal Aortic Aneurysm Patients
NCT02973308
Screening of Abdominal Aortic Aneurysms Among Male Patients With TIA Symptoms
NCT01850732
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main objective of this study was to screen the prevalence of AAA in OSAHS population by a cross-sectional study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* 2\. Received AAA related treatment;
* 3\. Past imaging test result suggested increased diameter of the abdominal aorta.
* 4\. Poor compliance; refused to follow the requirements set in this study follow-up, and refused to sign informed consent.
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Tsinghua Chang Gung Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Weiwei Wu, MD
Role: PRINCIPAL_INVESTIGATOR
Beijing Tsinghua Changgeng Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Tsinghua Changgung Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17084-0310
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.